Effects Of Unilateral Forearm Vibration On The Loss Of Muscle And Bone Of Contralateral Forearm (Vib-Frx)
The aim of the present study is to investigate the effects of vibrating the forearm bone in the free limb on muscle strength and bone mineral density of the forearm in patients with forearm/elbow fracture.
A total of 80 patients with forearm/elbow fracture are planned to include in this study. Patients will be randomly attained Training or Control group. Training period will be six weeks. Patients in the control group will receive standard care for provided for fractures, including fixation and rest.Before the start of the study and after six weeks, bilateral bone density of distal radius will be measured by DXA. Before trials, grip strength and the rest muscle electrical activity of contralateral wrist flexors and extensors will be measured. After six weeks, bilateral grip strength and the rest muscle electrical activity will be measured.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Basic Science
|Official Title:||Effects Of Unilateral Forearm Vibration On The Loss Of Muscle Strength And Bone Of The Contralateral Forearm Due to Forearm/Elbow Fracture|
- Change of forearm muscle strength [ Time Frame: baseline and 6 weeks ]Change of muscle strength with forearm vibration
- Change of distal radius bone mineral density [ Time Frame: baseline and 6 weeks ]Change of distal radius bone mineral density with forearm vibration
|Study Start Date:||September 2013|
|Estimated Study Completion Date:||March 2014|
|Estimated Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|
The forearm vibration training
Other: Forearm vibration
All cases will be trained by forearm vibration device 5 times a week for six weeks period.
Other Name: vibration training
No Intervention: Control
Patients will be treated by routine fracture treatment methods (fixation and rest).
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT01553487
|Bagcilar Training & Research Hospital|
|Study Chair:||ILHAN KARACAN, MD||Bagcilar Training & Research Hospital|